Advances in wound care and healing technology

American Journal of Clinical Dermatology

Volumn 1, Issue 5, 2000, Pages 269-275

  Natarajan, S ^a   Williamson, Diane ^a   Stiltz, Amanda J ^a   Harding, Keith G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL SKIN; BANDAGE; FORECASTING; GENE THERAPY; HUMAN; INJURY; PENETRATING TRAUMA; REVIEW; SKIN; WOUND HEALING;

BANDAGES; FORECASTING; GENE THERAPY; HUMANS; SKIN; SKIN, ARTIFICIAL; WOUND HEALING; WOUNDS, PENETRATING;

EID: 0034280420     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200001050-00002     Document Type: Review

References (54)

1. Naylor IL. Ulcer care in the Middle Ages. J Wound Care 1999; 8 (4): 208-12
2. Leibovich SJ, Ross R. The role of the macrophage in wound repair. Am J Pathol 1975; 78: 71-100
3. Martin P. Wound healing - aiming for perfect skin regeneration. Science 1997; 276: 75-81
4. McCallion RL, Ferguson MWJ. Fetal wound healing and the development of antiscarring therapies for adult wound healing. In: Clark RAF, editor. Molecular and cellular biology of wound repair. New York: Plenum Press, 1996: 561-600
5. Shah M, Foreman DM, Ferguson MWJ. Control of scarring in adult wounds by neutralising antibodies to transforming growth factor beta (TGF-β). Lancet 1992; 339: 213-4
6. Shah M, Foreman DM, Ferguson MWJ. Neutralising antibody to TGF-β1, 2 reduces scarring in adult rodents. J Cell Sci 1994; 107: 1137-57
7. Shah M, Foreman DM, Ferguson MWJ. Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995; 108: 985-1002
8. Winter GD. Formation of the scab and rate of epithelialisation of superficial wounds in the skin of the young domestic pig. Nature 1962; 193: 293-4
9. Moberg S, Hoffman L, Grennert M-L, et al. A randomised trial of cadexomer iodine in decubitus ulcers. J Am Geriatrics Soc 1983; 31: 462-5
10. Anzai T, Shiratori A, Ohtomo E, et al. Evaluation of clinical utility of NI-009 on various cutaneous ulcers. Comparative study with base. J Clin Ther Med 1989; 5: 2575-612
11. Eltringham I. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 1997; 35: 1-8
12. Houang ET, Gilmore OJA, Read C, et al. Absence of bacterial resistance to povidone iodine. J Clin Path 1976; 29: 752-5
13. Bowler PG, Jones SA, Davies BJ, et al. Infection control properties of some wound dressings. J Wound Care 1999; 8 (10): 499-502
14. Philips T, Kehinde O, Green H, et al. Treatment of skin ulcers with cultured epidermal allografts. J Am Acad Dermatol 1989; 21: 191-9
15. Falanga V, Margolis D, Alvaris O, et al. Rapid healing of venous leg ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol 1998; 134: 293-300
16. Rundle JS, Cameron SH, Ruckley CV. New porcine dermis for varicose and traumatic leg ulcers. BMJ 1976; 6029: 216
17. Dejardin LM, Arnoczky SP, Clarke RB. Use of small intestinal submucosal implants for regeneration of large fascial defects: an experimental study in dogs. J Biomed Mater Res 1999; 46: 203-11
18. Voytik-Harbin SL, Brightman AO, Kraine MR, et al. Identification of extractable growth factors from small intestinal submucosa. J Cell Biochem 1997; 67: 478-91
19. Scriven JM, Taylor LE, Wood AT, et al. A prospective randomised trial of four layer versus short stretch compression bandages for the treatment of venous leg ulcers. Ann R Coll Surg Engl 1998; 80: 215-20
20. Cullum N, Nelson EA, Fletcher AW, et al. Compression bandages and stockings in the treatment of venous leg ulcers. Issue 3. Oxford: Cochrane Library, Update Software, 1999
21. Ibbotson SH, Layton AM, Davies JA, et al. The effect of aspirin on haemostatic activity in the treatment of chronic venous leg ulceration. Br J Dermatol 1995; 132: 422-6
22. Layton AM, Ibboston SH, Davies JA, et al. Randomised trial of oral aspirin for chronic venous ulcers. Lancet 1994; 344: 164-5
23. Colgan MP, Dormandy JA, Jones PW, et al. Oxypentifylline treatment of venous ulcers of the leg. BMJ 1990; 300: 972-5
24. Falanga V, Fujitani RM, Diaz C, et al. Systemic treatment of venous leg ulcers with high dose pentoxifylline. Wound Rep Reg 1999; 7: 208-13
25. Dale JJ, Ruckley CV, Harper DR, et al. Randomised double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers. BMJ 1999; 319: 875-8
26. Chantelau E, Tanudjaja T, Altenhofer F, et al. Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial. Diabetic Med 1996; 13: 156-9
27. Edmonds E. Early use of antibiotics should not be ruled out. Diabetic Foot 1999; 2 (4): 135-8
28. Robson MC. Wound infection: a failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 1997; 77: 637-50
29. O'Dea K. The prevalence of pressure damage in acute care hospital patients in the UK. J Wound Care 1999; 8 (4): 192-4
30. Khan JS. Treatment of leprous trophic ulcer. Leprosy in India 1939; 11: 19-21
31. Sinacore DR, Mueller MJ, Diamond JE, et al. Diabetic plantar ulcers treated with contact casting. A clinical report. Phys Ther 1987; 67 (10): 1543-9
32. Laing PN, Cogley DI, Klenerman L. Neuropathic foot ulceration treated by total contact casts. J Bone Joint Surg 1992; 74B: 133-6
33. Baumbauer JF, Wervey R, McWilliams J, et al. A comparison study of plantar foot pressure in a standardised shoe, total contact cast and prefabricated pneumatic walking brace. Foot Ankle Int 1997; 18 (1): 26-33
34. Pavillard ER, Wright EA. An antibiotic from maggots. Nature 1957; 180: 916-7
35. Thomas S, Andrews A. The use of larval therapy in wound management. J Wound Care 1998; 7: 521-4
36. Vistnes LM, Lee R, Ksander GA. Proteolytic activity of blowfly larvae secretions in experimental burns. Surgery 1981; 90: 835-41
37. Prete P. Growth factors of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci 1997; 60: 505-10
38. Cooper RA. The inhibition of bacteria isolated from chronic leg ulcers by honey. J Med Microbiol 1998: 44: 1140
39. Molan PC, Brett M. Honey has potential as a dressing for wounds infected with MRSA. The Second Australian Wound Management Association Conference; 1998 March 18-21; Brisbane, Australia
40. Molan PC. The role of honey in the management of wounds. J Wound Care 1999; 8: 415-8
41. Hunt TK, Pai MP. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet 1972; 135: 561-7
42. Niinikoski J. Effect of oxygen supply on wound healing and formation of experimental granulation tissue. Acta Physiol Scand 1970; 334 (Suppl.): 4-72
43. Knighton DR, Silver IA, Hunt TK. Regulation of wound healing angiogenesis - effect of oxygen gradients and inspired oxygen concentration. Surgery 1981; 90: 262-70
44. Sheffield PJ. Tissue oxygen measurements with respect to soft tissue wound healing with normobaric and hyperbaric oxygen. Hyperbaric Oxygen Rev 1985; 6: 18-46
45. Hammarlund C, Sundberg T. Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double-blind study. Plast Reconstr Surg 1994; 93: 829-33
46. Flemming KA, Cullum NA, Nelson EA. A systematic review of laser therapy for venous leg ulcers. J Wound Care 1999; 8 (3): 111-4
47. Falanga V. Growth factors and wound healing. Dermatol Clin 1993; 11: 667-74
48. Knighton DR, Ciresi K, Fiegel VD, et al. Stimulation of repair in chronic nonhealing, cutaneous ulcers using platelet derived wound healing formula. Surg Gynecol Obstet 1990; 170: 56-60
49. Steed DL, Goslen JB, Holloway GA. Randomized prospective double blind trial in healing chronic diabetic foot ulcers. Diabetes Care 1992; 15: 1598-604
50. Steed DL, Donohoe D, Webster MW, et al. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. J Am Coll Surg 1996; 183: 61-4
51. Wieman TJ, Smiell JM, Yachin S. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (Becaplermin) in patients with chronic neuropathic diabetic ulcers. Diabetes Care 1998; 21: 822-7
52. Eming SA, Lee J, Snow RG, et al. Genetically modified human epidermis over-expressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice: implications for the use of genetically modified keratinocytes to modulate dermal regeneration. J Invest Dermatol 1995; 105: 756-63
53. Andree C, Swain WF, Page CP, et al. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci 1994; 91: 12188-92
54. Graham A. The use of growth factors in clinical practice. J Wound Care 1998; 7: 536-5